Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

304 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Angiogenic factors in relation to clinical effect in a phase II trial of weekly paclitaxel.
Linderholm BK, Lidbrink E, Tallroth E, Einbeigi Z, Svensson H, von Wachenfeldt A, Norberg B, Carlsson L, Olsson ME, Bergh J, Wilking N, Hatschek T. Linderholm BK, et al. Among authors: norberg b. Breast. 2013 Dec;22(6):1142-7. doi: 10.1016/j.breast.2013.07.041. Epub 2013 Aug 20. Breast. 2013. PMID: 23968864 Free article. Clinical Trial.
Second-line endocrine treatment of advanced breast cancer--a randomized cross-over study of medroxy-progesterone acetate and aminoglutethimide.
Hultborn R, Johansson-Terje I, Bergh J, Glas U, Hallsten L, Hatschek T, Holmberg E, Ideström K, Norberg B, Ranstam J, Söderberg M, Wallgren UB. Hultborn R, et al. Among authors: norberg b. Acta Oncol. 1996;35 Suppl 5:75. doi: 10.3109/02841869609083975. Acta Oncol. 1996. PMID: 9142972 Clinical Trial. No abstract available.
Pegylated liposomal doxorubicin as first-line monotherapy in elderly women with locally advanced or metastatic breast cancer: novel treatment predictive factors identified.
Green H, Stål O, Bachmeier K, Bäcklund LM, Carlsson L, Hansen J, Lagerlund M, Norberg B, Franzén Å, Åleskog A, Malmström A. Green H, et al. Among authors: norberg b. Cancer Lett. 2011 Dec 27;313(2):145-53. doi: 10.1016/j.canlet.2011.07.017. Epub 2011 Aug 31. Cancer Lett. 2011. PMID: 22056077 Free article. Clinical Trial.
Patients' preferences for subcutaneous trastuzumab versus conventional intravenous infusion for the adjuvant treatment of HER2-positive early breast cancer: final analysis of 488 patients in the international, randomized, two-cohort PrefHer study.
Pivot X, Gligorov J, Müller V, Curigliano G, Knoop A, Verma S, Jenkins V, Scotto N, Osborne S, Fallowfield L; PrefHer Study Group. Pivot X, et al. Ann Oncol. 2014 Oct;25(10):1979-1987. doi: 10.1093/annonc/mdu364. Epub 2014 Jul 28. Ann Oncol. 2014. PMID: 25070545 Free article. Clinical Trial.
[Clinical experiences with Levemir treatment].
Jendle J, Norberg B. Jendle J, et al. Among authors: norberg b. Lakartidningen. 2007 Jan 10-16;104(1-2):54. Lakartidningen. 2007. PMID: 17323744 Swedish. No abstract available.
304 results